XBIT Stock Analysis: Buy, Sell, or Hold?
XBIT - XBiotech Inc
$2.49
-0.02 (-0.60%)
▼
5d:
-2.55%
30d:
+6.65%
90d:
+4.85%
BUY
MODERATE Confidence
Analysis Updated: May 7, 2026 12:00 AM ET
Earnings: May 13, 2026
4d
Get Alerted When XBIT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: XBIT shows positive signals but monitor for confirmation. Moderate conviction.
💡 BUY OPPORTUNITY: XBIT shows positive signals but monitor for confirmation. Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: XBIT is currently trading at $2.48, which is considered fair relative to its 30-day fair value range of $2.36 to $2.55.
Technical Outlook: Technically, XBIT is showing sideways momentum. The price is currently testing key support at $2.47. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $18.00 (+620.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, XBIT is showing sideways momentum. The price is currently testing key support at $2.47. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $18.00 (+620.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$2.36 -
$2.55
Company Quality Score
49/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
74.7%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 620.0% below Wall St target ($18.00)
Trading Range Analysis
30-Day Trading Range
$2.36 -
$2.55
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$2.47
Resistance Level
$2.65
Current Trend
Sideways
Technical data as of
May 8, 2026
Fundamental Context
Wall Street Target
$18.00
(+620.0%)
Revenue Growth (YoY)
-93.3%
Share & Embed Analysis
Last updated: May 08, 2026 1:47 PM ET
Data refreshes hourly during market hours. Next update: 2:47 PM
Data refreshes hourly during market hours. Next update: 2:47 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is XBIT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
33 analysts |
$449 | 52 HOLD |
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$22 | 53 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$36 | 65 BUY |
|
INSM
Insmed Inc |
STRONG BUY
19 analysts |
$213 | 46 HOLD |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$9 | 54 HOLD |
